Monoclonal antibodies against antithrombin β
This patent document relates to antibodies, antigen-binding antibody fragments (Fabs), and other protein scaffolds, directed against human antithrombin β complexed with heparin and/or heparin-like structure (ATβH). These ATβH binding proteins can block the anti-coagulant activity of ATβ to induce coagulation. Therapeutic uses of these antibodies and binders are described herein as are methods of panning and screening specific antibodies.
1. A monoclonal antibody capable of binding AtβH, wherein the heavy chain of said antibody comprises: a HCDR1 comprising SEQ ID NO: 40, a HCDR2 comprising SEQ ID NO: 45, and a HCDR3 comprising SEQ ID NO: 50; and
wherein the light chain of said antibody comprises: a LCDR1 comprising SEQ ID NO: 21, a LCRD2 comprising SEQ ID NO: 26, and a LCDR3 comprising SEQ ID NO: 31.